Article ID Journal Published Year Pages File Type
3847065 Advances in Chronic Kidney Disease 2011 12 Pages PDF
Abstract
Judicious control of PO4 early in CKD, possibly monitored by measures of FGF-23, could potentially reduce the risk of development of renal secondary hyperparathyroidism and all of the adverse clinical consequences of poorly controlled CKD-mineral and bone disorder. The mainstays of therapy are likely to include a balance of dietary restriction and PO4 binders to reduce PO4 input, and in ESRD patients, dialysis modalities to augment PO4 output.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, ,